Feed 6617.TWO
66
Gongwin Biopharm Holdings Co., Ltd.
6617.TWO · TWO
$105.50 +9.55% (+$9.20)
1M -8.29%
Market Cap $11.7B
P/E Ratio -
Div. Yield -
ROE 5.73%
Valuation
20 /100
Expensive P/B 4.86x
P/S 304.89x
EV/EBITDA N/A
Growth
100 /100
Growing Book val. growth 22.06%
Rev. growth 217.10%
FCF growth N/A
Profitability
20 /100
Weak Net margin 370.96%
Op. margin 588.88%
FCF margin 255.07%
Quality
0 /100
Poor ROE 5.73%
ROA 5.31%
Asset turnover 0.01x
Debt
69 /100
Low Current ratio 9.19x
Int. coverage -47.99x
Debt/Equity 0.06x
Stability
15 /100
Unstable Rev. volatility 874.14%
EPS volatility 49.97%
Profitable years 0
Vprašajte StockBota o 6617.TWO
Online
Sector
Healthcare
Industry
Medical - Distribution
CEO
Chonghan Wu
Employees
20
Headquarters
Taipei